Adiponectin can not only inhibit tumor progression by regulating tumor cell proliferation and inducing the apoptosis response but also has unique anti-inflammatory and anti-insulin resistance effects that are very important for the treatment of obesity induced tumors, especially in breast cancer, pancreatic cancer and colorectal cancer (57). This evidence concerns the gene ADIPOQ and familial pancreatic carcinoma.